Breaking boundaries: Current progress of anticancer NK cell-based drug development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breaking boundaries: Current progress of anticancer NK cell-based drug development

Published:2023-02 Issue:2 Volume:28 Page:103436
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Wang Shuhang,Chen Kun,Jiang Yale,Zhao Guo,Wang Caie,Fang Hong,Tang Qiyu,Sun Chao,Zhang Liang,Wu Haiyang,Zhang Li-Feng,Li Ning

Funder

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing Municipal Science and Technology Commission

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference58 articles.

1. Human natural killer cells;Caligiuri;Blood,2008

2. Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders;Maskalenko;Nat Rev Drug Discov,2022

3. Innate or adaptive immunity? The example of natural killer cells;Vivier;Science,2011

4. NK cell-based cancer immunotherapy: from basic biology to clinical development;Liu;J Hematol Oncol,2021

5. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications;Sivori;Cell Mol Immunol,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The SUMOylation inhibitor TAK-981 (Subasumstat) triggers IFN-I-dependent activation of Natural Killer cells against Acute Myeloid Leukemias;2024-02-21

2. Application of chimeric antigen receptor-natural killer cells for the treatment of type 1 diabetes;Exploration of Endocrine and Metabolic Disease;2023-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP